- PMID 19491814.
Mikhaylova M,
Vakhitova JV,
Yamidanov RS,
Salimgareeva MK,
Seredenin SB,
Behnisch T (October 2007). "The
effects of
ladasten on dopaminergic...
- DVD-111; GVS 111;
Noopept Ostrovskaia RU,
Gudasheva TA,
Voronina TA,
Seredenin SB (2002). "[The
original novel nootropic and
neuroprotective agent noopept]"...
- 21
March 2015.
Neznamov GG,
Siuniakov SA,
Chumakov DV,
Bochkarev VK,
Seredenin SB (2001). "[Clinical
study of the
selective anxiolytic agent afobazol]"...
- p. 299. ISBN 9781477156995. Daugel'-Dauge NO,
Durnev AD,
Kulakova AV,
Seredenin SB, Velichkovskiĭ BT (1995). "[Corpuscular
mutagenesis and its prevention]"...
- PMID 6104993. Neznamov, GG; Siuniakov, SA; Chumakov, DV; Bochkarev, VK;
Seredenin, SB (2001). "Clinical
study of the
selective anxiolytic agent afobazol"...
-
range of doses.
Mokrov GV,
Deeva OA,
Gudasheva TA,
Yarkov SA,
Yarkova MA,
Seredenin SB (Jul 2015). "Design,
synthesis and anxiolytic-like
activity of 1-arylpyrrolo[1...
-
October 2024.
Gudasheva TA,
Grigoriev VV,
Koliasnikova KN,
Zamoyski VL,
Seredenin SB (November 2016). "Neuropeptide
cycloprolylglycine is an endogenous...
- PMID 38128028.
Mikhaylova M,
Vakhitova JV,
Yamidanov RS,
Salimgareeva MK,
Seredenin SB,
Behnisch T (October 2007). "The
effects of
ladasten on dopaminergic...
- PMID 32514120.
Katnik C,
Garcia A,
Behensky AA,
Yasny IE,
Shuster AM,
Seredenin SB, et al. (February 2014). "Treatment with
afobazole at dela**** time...
- PMID 22886028.
Gudasheva TA,
Grigoriev VV,
Koliasnikova KN,
Zamoyski VL,
Seredenin SB (November 2016). "Neuropeptide
cycloprolylglycine is an endogenous...
